ArticleInternational journal of clinical pharmacy2024

Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system.

Wanlong Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.